HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A repeated 28-day oral dose toxicity study of 17alpha-methyltestosterone in rats, based on the 'enhanced OECD Test Guideline 407' for screening the endocrine-disrupting chemicals.

Abstract
As part of the international validation project to establish the Enhanced OECD Test Guideline 407, we performed a 28-day repeated-dose toxicity study of 17alpha-methyltestosterone, an exogenous androgen agonist. Special attention was paid to the sensitivity of additional parameters for detecting endocrine-related effects of endocrine-disrupting chemicals, based on the existing Test Guideline 407. Seven-week-old Crj:CD(SD)IGS rats were allocated to one of four groups, each consisting of ten males and ten females, and 17alpha-methyltestosterone was administered daily by gavage at doses of 0 (control), 5, 20 and 80 mg/kg body weight per day. Male rats were killed on the day after the 28th administration and females on the day of the diestrus stage during the 4 day period after the 28th administration. Male rats receiving 80 mg/kg 17alpha-methyltestosterone demonstrated decreases in testis and epididymis weights, atrophy of seminiferous tubules and Leydig cells, and degenerated pachytene spermatocytes in the testes and degenerated germ cells in the epididymides as major alterations. Female rats showed abnormal estrous cycles, decreases in ovary and adrenal weights, increase in immature follicles with decreased corpus lutea in the ovaries at doses of 5 mg/kg and higher, as well as atrophy of zona reticularis in the adrenals and increase in mammary gland secretion at 20 mg/kg and above. Dilatation of the lumina and apoptosis of endometrial cells in the uterus, mucinification in the vagina and increase in serum follicle-stimulating hormone were seen with 80 mg/kg. Among the parameters examined in the present experimental system, effects of 17alpha-methyltestosterone on endocrine-related organs were detected in organ weights and histopathological examination of both sexes, and in serum hormones and estrous cycle of females. Based on these results, the no-observed-adverse-effect level (NOAEL) in the present study was estimated to be below 5 mg/kg per day. In particular, effects were most sensitively detected by organ weights and histopathological examination of sexual organs.
AuthorsKazushi Okazaki, Takayoshi Imazawa, Hideaki Nakamura, Fumio Furukawa, Akiyoshi Nishikawa, Masao Hirose
JournalArchives of toxicology (Arch Toxicol) Vol. 75 Issue 11-12 Pg. 635-42 (Jan 2002) ISSN: 0340-5761 [Print] Germany
PMID11876496 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hormone Antagonists
  • Testosterone Congeners
  • Follicle Stimulating Hormone
  • Methyltestosterone
Topics
  • Administration, Oral
  • Animals
  • Dose-Response Relationship, Drug
  • Estrous Cycle (drug effects)
  • Female
  • Follicle Stimulating Hormone (blood)
  • Genitalia, Female (drug effects, pathology)
  • Genitalia, Male (drug effects, pathology)
  • Hormone Antagonists (administration & dosage, toxicity)
  • Male
  • Methyltestosterone (administration & dosage, toxicity)
  • No-Observed-Adverse-Effect Level
  • Organ Size (drug effects)
  • Rats
  • Rats, Inbred Strains
  • Testosterone Congeners (administration & dosage, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: